|
STAT2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.82761999999448E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.66080000002711E-06 |
| Normal-vs-Stage2 |
6.594800E-01 |
| Normal-vs-Stage3 |
2.061700E-03 |
| Normal-vs-Stage4 |
2.714300E-02 |
| Stage1-vs-Stage2 |
2.129900E-02 |
| Stage1-vs-Stage3 |
5.269000E-01 |
| Stage1-vs-Stage4 |
7.345000E-01 |
| Stage2-vs-Stage3 |
7.165500E-02 |
| Stage2-vs-Stage4 |
1.258190E-01 |
| Stage3-vs-Stage4 |
9.077000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.85009999986718E-07 |
| Normal-vs-AfricanAmerican |
1.236380E-02 |
| Normal-vs-Asian |
2.084900E-03 |
| Caucasian-vs-AfricanAmerican |
7.430000E-01 |
| Caucasian-vs-Asian |
8.510000E-01 |
| AfricanAmerican-vs-Asian |
8.704400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.811500E-04 |
| Normal-vs-Female |
3.99560000000632E-05 |
| Male-vs-Female |
9.830400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.23320000000593E-06 |
| Normal-vs-Age(41-60Yrs) |
4.038800E-04 |
| Normal-vs-Age(61-80Yrs) |
2.938000E-01 |
| Normal-vs-Age(81-100Yrs) |
7.869800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.920010E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.553700E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.027200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.044400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.227600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.495200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.550000E-01 |
| Classical-VS-Follicular |
2.99760216648792E-15 |
| Classical-VS-Other |
3.457500E-02 |
| Classical-VS-Normal |
1.88559945435429E-10 |
| Tall-VS-Follicular |
4.45680000005222E-06 |
| Tall-VS-Other |
2.942200E-02 |
| Tall-VS-Normal |
9.170700E-04 |
| Follicular-VS-Other |
5.744200E-01 |
| Follicular-VS-Normal |
8.183700E-03 |
| Other-VS-Normal |
5.198800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.030160E-02 |
| Normal-vs-N1 |
9.246800E-04 |
| N0-vs-N1 |
1.612810E-01 |
|
|
